Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test symbols : Qgen save search
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
Published: 2024-03-25 (Crawled : 20:00) - globenewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.59%
H: 1.33%
C: 1.33%
test system collaboration results
Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published: 2023-12-11 (Crawled : 17:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.02%
H: 0.9%
C: 0.77%
NVS | News | $97.515 0.24% 820K
|
Health Technology
|
| O: 0.75%
H: 0.55%
C: 0.27%
DHR | $250.045 -1.21% 660K
|
Health Technology
|
| O: 0.27%
H: 1.66%
C: 1.5%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.02%
H: 0.9%
C: 0.77%
disease report test distribution global market
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
Published: 2023-02-14 (Crawled : 23:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.27%
H: 0.6%
C: 0.08%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.27%
H: 0.6%
C: 0.08%
blood test plus
HPV Testing and Pap Test Market by Test Type, End User and Region - Global Forecast to 2027
Published: 2022-12-20 (Crawled : 20:00) - prnewswire.com
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.06%
H: 1.37%
C: 0.76%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: 0.69%
H: 1.41%
C: 0.96%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: 0.56%
H: 1.21%
C: 0.98%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.06%
H: 1.37%
C: 0.76%
HOLX | $76.635 -0.72% 110K
|
Health Technology
|
| O: 0.69%
H: 1.9%
C: 1.09%
ERIC | News | $5.21 -2.8% 5.9M
|
Electronic Technology
|
| O: 1.22%
H: 0.34%
C: 0.17%
global test hpv market
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
Published: 2022-11-21 (Crawled : 00:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
monkeypox research global test platform
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
monkeypox device global test health
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.39%
H: 1.92%
C: 1.55%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.39%
H: 1.92%
C: 1.55%
test platform
Global HIV Diagnostics Test Market to Surpass US$ 8,487.17 Million by 2030 - Coherent Market Insights
Published: 2022-06-21 (Crawled : 18:00) - prnewswire.com
VTRS | News A | $11.34 -0.18% 900K
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
TRIB | $1.83 520
|
Health Technology
|
| O: 0.0%
H: 4.72%
C: 1.57%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
OSUR | News | $5.45 -1.45% 120K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
HOLX | $76.635 -0.72% 110K
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
test hiv diagnostics market
European Infectious Disease Diagnostics Industry to 2031 - Technological Advancements in Molecular Techniques and Infectious Diagnostic Tests Presents Opportunities
Published: 2022-05-20 (Crawled : 11:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: 3.64%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 3.64%
H: 1.64%
C: -0.75%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: 1.57%
H: 0.42%
C: -0.04%
A | $137.89 -0.94% 220K
|
Health Technology
|
| O: 3.19%
H: 1.25%
C: 0.89%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
ILMN | $121.115 -2.69% 160K
|
Health Technology
|
| O: 2.6%
H: 0.49%
C: -0.55%
disease diagnostic diagnostics molecular test
QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
Published: 2022-05-16 (Crawled : 08:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 1.97%
H: 1.37%
C: 0.54%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 1.97%
H: 1.37%
C: 0.54%
test
Global Genetic Testing Market Report 2022-2026: Genetic Testing Market Witnesses Sluggish Growth during COVID-19, Set to Record Exponential Growth Post-COVID
Published: 2022-03-24 (Crawled : 19:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.23%
C: -1.36%
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.55%
H: 0.14%
C: -1.96%
LH M | $206.1 -0.9% 110K
|
Health Services
|
| O: 0.57%
H: 0.5%
C: 0.36%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.52%
H: 0.23%
C: -1.36%
NTRA | News M | $92.61 1.73% 140K
|
Health Services
|
| O: 4.14%
H: 0.0%
C: 0.0%
ILMN | $121.115 -2.69% 160K
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.18%
covid-19 genetic report growth set market test covid
QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used to Detect TB
Published: 2022-03-24 (Crawled : 09:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.23%
H: 0.37%
C: 0.27%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -1.23%
H: 0.37%
C: 0.27%
100 quantiferon milestone test
Global Pneumococcal Testing Market Research Report to 2027 - by Method, Technology, Product Type, End-user and Region
Published: 2022-03-23 (Crawled : 14:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
DGX | News | $135.665 -0.76% 320K
|
Health Services
|
| O: -0.68%
H: 0.32%
C: -0.31%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
NVS | News | $97.515 0.24% 820K
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: -1.2%
H: 0.29%
C: -2.92%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: -0.97%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
TRIB | $1.83 520
|
Health Technology
|
| O: -0.94%
H: 4.76%
C: 2.38%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
HOLX | $76.635 -0.72% 110K
|
Health Technology
|
| O: -0.28%
H: 0.28%
C: -1.2%
research report market test pneumococcal
Global COVID-19 Rapid Test Kits Market Research Report 2022 Featuring Abbott Laboratories, F. Hoffmann-La Roche AG, Quidel, Thermo Fisher Scientific, and Becton, Dickinson and Co
Published: 2022-03-15 (Crawled : 21:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: 2.88%
H: 1.64%
C: 1.03%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 2.52%
H: 2.24%
C: 1.62%
BIO | $278.46 -2.39% 51K
|
Health Technology
|
| O: 1.73%
H: 2.97%
C: 0.82%
BDX | $232.77 -0.68% 250K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: 0.78%
H: 1.13%
C: 1.07%
QDEL | News 4 | $39.29 -2.75% 230K
|
Health Technology
|
| O: 1.85%
H: 1.97%
C: 1.77%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 2.52%
H: 2.24%
C: 1.62%
covid-19 research covid report test
Global Automated and Rapid Microbiological Tests Market to Reach $7.6 Billion by 2026
Published: 2022-03-04 (Crawled : 16:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: -1.89%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -4.35%
H: 0.0%
C: 0.0%
ABT | News | $105.9 -1.57% 1.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
QDEL | News 4 | $39.29 -2.75% 230K
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -4.35%
H: 0.0%
C: 0.0%
OSUR | News | $5.45 -1.45% 120K
|
Health Technology
|
| O: -3.39%
H: 0.0%
C: 0.0%
HOLX | $76.635 -0.72% 110K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
test
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
Published: 2022-02-07 (Crawled : 10:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
chinese approval test quantiferon
Global Genomics Markets, 2022-2026 - Healthcare Shift Towards Precision Medicine , Third-Generation Sequencing (TGS), Exome Sequencing, & Direct-to-consumer Genetic Testing
Published: 2022-02-04 (Crawled : 18:00) - prnewswire.com
TMO | News | $569.96 -0.81% 530K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
health genetic genomics genomic thc test
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
Published: 2022-01-10 (Crawled : 18:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: -4.06%
H: 2.48%
C: 2.43%
syndros test
Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.27 -1.48% 320K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $1.93 64.96% 55M
|
AMST | $3.14 57.0% 59M
|
Technology Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
LICN | $0.7885 40.8% 11M
|
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.